These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8923590)

  • 1. Systemic sclerosis. A vascular perspective.
    LeRoy EC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):675-94. PubMed ID: 8923590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of systemic sclerosis.
    White B
    Rheum Dis Clin North Am; 1996 Nov; 22(4):695-708. PubMed ID: 8923591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of scleroderma (systemic sclerosis, SSc).
    LeRoy EC; Trojanowska M; Smith EA
    Clin Exp Rheumatol; 1991; 9(2):173-7. PubMed ID: 2060163
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular disease in scleroderma: mechanisms of vascular injury.
    Kahaleh B
    Rheum Dis Clin North Am; 2008 Feb; 34(1):57-71; vi. PubMed ID: 18329532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasculopathy of Raynaud's phenomenon and scleroderma.
    Flavahan NA; Flavahan S; Mitra S; Chotani MA
    Rheum Dis Clin North Am; 2003 May; 29(2):275-91, vi. PubMed ID: 12841295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vascular perspective of systemic sclerosis: of chickens, mice and men.
    Sgonc R
    Int Arch Allergy Immunol; 1999 Nov; 120(3):169-76. PubMed ID: 10592461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular endothelium in scleroderma.
    Kahaleh MB
    Int Rev Immunol; 1995; 12(2-4):227-45. PubMed ID: 7650422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vascular manifestations in systemic sclerosis (scleroderma)].
    Cafagna D; Melon F; Balbi M; Ponte E
    Minerva Med; 1998 May; 89(5):153-61. PubMed ID: 9676180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic sclerosis: from physiopathology to treatment].
    Mouthon L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S266-72. PubMed ID: 17950498
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunopathogenesis of fibrosis in systemic sclerosis.
    Brown M; O'Reilly S
    Clin Exp Immunol; 2019 Mar; 195(3):310-321. PubMed ID: 30430560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular changes in the pathogenesis of systemic sclerosis].
    Distler JH; Kalden JR; Gray S; Distler O
    Z Rheumatol; 2004 Dec; 63(6):446-50. PubMed ID: 15605207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular involvement in systemic sclerosis (SSc).
    Kahaleh MB
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S19-23. PubMed ID: 15344592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vascular defect in scleroderma (systemic sclerosis).
    Leroy EC
    Acta Med Scand Suppl; 1987; 715():165-7. PubMed ID: 3495959
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.
    Guiducci S; Distler O; Distler JH; Matucci-Cerinic M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v18-20. PubMed ID: 18784130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease.
    Koch AE; Kronfeld-Harrington LB; Szekanecz Z; Cho MM; Haines GK; Harlow LA; Strieter RM; Kunkel SL; Massa MC; Barr WG
    Pathobiology; 1993; 61(5-6):239-46. PubMed ID: 7507681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
    Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
    Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.